Kathryn M. Johnson, Ph.D.
Affiliations: | 2005 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
anti-DNA autoantibody structure and function, and the identification of novel molecular targets and small molecules for the treatment of autoimmune diseases and cancerGoogle:
"Kathryn Johnson"Mean distance: 8.64 | S | N | B | C | P |
Parents
Sign in to add mentor| Gary D. Glick | grad student | 2005 | University of Michigan | |
| (Elucidation of the target and molecular mechanism of action of the immunomodulatory benzodiazepine, Bz-423.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Starke I, Johnson KM, Petersen J, et al. (2016) Binding of the immunomodulatory drug Bz-423 to mitochondrial F |
| Johnson KM, Swenson L, Opipari AW, et al. (2009) Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin. Biopolymers. 91: 830-40 |
| Cleary J, Johnson KM, Opipari AW, et al. (2007) Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor. Bioorganic & Medicinal Chemistry Letters. 17: 1667-70 |
| Johnson KM, Cleary J, Fierke CA, et al. (2006) Mechanistic basis for therapeutic targeting of the mitochondrial F1F0-ATPase. Acs Chemical Biology. 1: 304-8 |
| Johnson KM, Chen X, Boitano A, et al. (2005) Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423. Chemistry & Biology. 12: 485-96 |
| Blatt NB, Bednarski JJ, Warner RE, et al. (2002) Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility. The Journal of Clinical Investigation. 110: 1123-32 |